INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845P958. A total of 5 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $15,000 | -51.6% | 38,300 | +6.1% | 0.01% | -50.0% |
Q3 2021 | $31,000 | +55.0% | 36,100 | +15.3% | 0.01% | +40.0% |
Q2 2020 | $20,000 | -73.7% | 31,300 | +3.3% | 0.01% | -78.7% |
Q1 2020 | $76,000 | +7500.0% | 30,300 | +4228.6% | 0.05% | +4600.0% |
Q2 2019 | $1,000 | -99.4% | 700 | -99.2% | 0.00% | -99.0% |
Q1 2019 | $172,000 | -85.6% | 92,611 | -34.3% | 0.10% | -89.4% |
Q4 2018 | $1,195,000 | – | 141,000 | – | 0.90% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Caligan Partners LP | 1,200,000 | $22,248,000 | 10.22% |
GROUP ONE TRADING, L.P. | 24,800 | $459,792 | 0.00% |
SIMPLEX TRADING, LLC | 53,200 | $986 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
JANE STREET GROUP, LLC | 68,500 | $1,269,990 | 0.00% |